CIK: 0001381843 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Jul 26, 2016
Total Value ($000): $218,086 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ANIK | ANIKA THERAPEUTICS INC | 412,588 | $22,135 | 10.1% | $38.50 | +22.4% | COM | 035255108 |
| — | GNC HLDGS INC | 681,955 | $16,565 | 7.6% | $30.08 | — | COM CL A | 36191G107 |
| — | AMAG PHARMACEUTICALS INC | 671,585 | $16,064 | 7.4% | $28.17 | — | COM | 00163U106 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 657,533 | $13,394 | 6.1% | $17.80 | -0.3% | COM | 868459108 |
| — | TRIPLE-S MGMT CORP | 532,876 | $13,018 | 6.0% | $19.84 | — | CL B | 896749108 |
| MRK | MERCK & CO INC | 224,100 | $12,910 | 5.9% | $36.03 | +9.6% | COM | 58933Y105 |
| COR | AMERISOURCEBERGEN CORP | 160,000 | $12,691 | 5.8% | $59.88 | 0.0% | COM | 03073E105 |
| — | FEI CO | 118,609 | $12,677 | 5.8% | $82.13 | — | COM | 30241L109 |
| — | TARO PHARMACEUTICAL INDS LTD | 86,205 | $12,551 | 5.8% | $143.25 | — | SHS | M8737E108 |
| CAH | CARDINAL HEALTH INC | 160,000 | $12,482 | 5.7% | $60.27 | 0.0% | COM | 14149Y108 |
| CRL | CHARLES RIV LABS INTL INC | 149,612 | $12,334 | 5.7% | $63.72 | +29.3% | COM | 159864107 |
| ELV | ANTHEM INC | 93,900 | $12,333 | 5.7% | $119.87 | +0.0% | COM | 036752103 |
| — | LIFEPOINT HEALTH INC | 185,851 | $12,149 | 5.6% | $67.19 | — | COM | 53219L109 |
| — | CONCORDIA INTL CORP | 543,000 | $11,696 | 5.4% | $21.54 | — | COM | 20653P102 |
| — | INC RESH HLDGS INC | 286,270 | $10,915 | 5.0% | $41.21 | — | CL A | 45329R109 |
| — | INSYS THERAPEUTICS INC NEW | 788,175 | $10,199 | 4.7% | $12.94 | — | COM NEW | 45824V209 |
| OSUR | ORASURE TECHNOLOGIES INC | 475,771 | $2,812 | 1.3% | $6.47 | +9.9% | COM | 68554V108 |
| ICCC | IMMUCELL CORP | 168,323 | $1,161 | 0.5% | $5.29 | +27.6% | COM PAR $0.10 | 452525306 |